In patients with IBS, there is a downregulation of TGR5 expression levels, which is associated with diminished intestinal peristalsis, decreased neuronal excitability, altered visceral sensitivity, and a reduced release of anti-inflammatory factors. This evidence concerns the gene GPBAR1 and irritable bowel syndrome.